Use filters to refine the search results.
Results 1-3 of 3
|4-Jan-2017||Targeting of Aberrant alpha v beta 6 Integrin Expression in Solid Tumors Using Chimeric Antigen Receptor-Engineered T Cells||Whilding, LM; Parente-Pereira, AC; Zabinski, T; Davies, DM; Petrovic, RMG, et al|
|28-Mar-2017||Methylation of MYLK3 gene promoter region: a biomarker to stratify surgical care in ovarian cancer in a multi-centre study||Phelps, DL; Borley, J; Flower, K; Dina, R; Darb-Esfahani, S, et al|
|5-Feb-2017||Is there a role for epigenetic enhancement of immunomodulatory approaches to cancer treatment?||Flower, KJ; Ghaem-Maghami, S; Brown, R; Imperial College Healthcare NHS Trust- BRC Funding; Imperial College Healthcare NHS Trust- BRC Funding|